收费全文 | 10055篇 |
免费 | 929篇 |
国内免费 | 26篇 |
耳鼻咽喉 | 202篇 |
儿科学 | 457篇 |
妇产科学 | 267篇 |
基础医学 | 1199篇 |
口腔科学 | 256篇 |
临床医学 | 970篇 |
内科学 | 1970篇 |
皮肤病学 | 201篇 |
神经病学 | 1022篇 |
特种医学 | 289篇 |
外科学 | 1371篇 |
综合类 | 255篇 |
一般理论 | 9篇 |
预防医学 | 954篇 |
眼科学 | 204篇 |
药学 | 656篇 |
中国医学 | 19篇 |
肿瘤学 | 709篇 |
2023年 | 94篇 |
2022年 | 179篇 |
2021年 | 338篇 |
2020年 | 244篇 |
2019年 | 351篇 |
2018年 | 358篇 |
2017年 | 266篇 |
2016年 | 242篇 |
2015年 | 286篇 |
2014年 | 374篇 |
2013年 | 455篇 |
2012年 | 663篇 |
2011年 | 623篇 |
2010年 | 341篇 |
2009年 | 377篇 |
2008年 | 540篇 |
2007年 | 488篇 |
2006年 | 489篇 |
2005年 | 455篇 |
2004年 | 412篇 |
2003年 | 370篇 |
2002年 | 333篇 |
2001年 | 239篇 |
2000年 | 234篇 |
1999年 | 206篇 |
1998年 | 95篇 |
1997年 | 71篇 |
1996年 | 81篇 |
1995年 | 55篇 |
1994年 | 59篇 |
1993年 | 50篇 |
1992年 | 127篇 |
1991年 | 101篇 |
1990年 | 113篇 |
1989年 | 99篇 |
1988年 | 89篇 |
1987年 | 90篇 |
1986年 | 94篇 |
1985年 | 92篇 |
1984年 | 71篇 |
1983年 | 55篇 |
1982年 | 52篇 |
1981年 | 37篇 |
1979年 | 48篇 |
1978年 | 41篇 |
1977年 | 41篇 |
1976年 | 40篇 |
1975年 | 49篇 |
1974年 | 49篇 |
1968年 | 47篇 |
Background
Clear cell renal cell carcinoma (ccRCC) is known to occur across the adult lifetime traversing the spectrum of age-related organismal changes. Little is known as to how the aging process may affect the course of renal cell carcinoma (RCC) and the repertoire of genes involved.Methods
Using The Cancer Genome Atlas (n?=?436) and Cancer Genomics of the Kidney (n?=?89) datasets, we applied regression analysis to examine associations between patient age and gene expression profiles in ccRCC tumors and normal kidney tissues. Pathway enrichment analysis was performed to identify cellular process that is affected by aging in ccRCC. Moreover, connectivity mapping analysis was used to predict age-dependent response to drug treatments.Results
Our analysis revealed different age-dependent gene expression spectra in ccRCC and normal kidney tissues. These findings were significant and independently reproducible in both datasets examined. Age up-regulated genes, showing higher expression in older patients, were significantly enriched (false discovery rate <0.05) in normal tissues for pathways associated with immune response and extracellular matrix organization, whereas age up-regulated genes in tumors were enriched for metabolism and oxidation pathways. Strikingly, age down-regulated genes in normal cells were also enriched for metabolism and oxidation, while those in tumors were enriched for extracellular matrix organization. Further in silico analysis of potential drug targets predicted preferential efficacy of Phosphoinositide 3-kinase inhibitor or immunotherapy in association with age.Conclusion
We report on previously unrecognized associations between age and molecular underpinnings of RCC, including age-associated expression of genes implicated in RCC development or treatment. 相似文献The metabolism of the pyrethroids deltamethrin (DLM), cis-permethrin (CPM) and trans-permethrin (TPM) was studied in human expressed cytochrome P450 (CYP) and carboxylesterase (CES) enzymes.
DLM, CPM and TPM were metabolised by human CYP2B6 and CYP2C19, with the highest apparent intrinsic clearance (CLint) values for pyrethroid metabolism being observed with CYP2C19. Other CYP enzymes contributing to the metabolism of one or more of the three pyrethroids were CYP1A2, CYP2C8, CYP2C9*1, CYP2D6*1, CYP3A4 and CYP3A5. None of the pyrethroids were metabolised by CYP2A6, CYP2E1, CYP3A7 or CYP4A11.
DLM, CPM and TPM were metabolised by both human CES1 and CES2 enzymes.
Apparent CLint values for pyrethroid metabolism by CYP and CES enzymes were scaled to per gram of adult human liver using abundance values for microsomal CYP enzymes and for CES enzymes in liver microsomes and cytosol. TPM had the highest and CPM the lowest apparent CLint values for total metabolism (CYP and CES enzymes) per gram of adult human liver.
Due to their higher abundance, all three pyrethroids were extensively metabolised by CES enzymes in adult human liver, with CYP enzymes only accounting for 2%, 10% and 1% of total metabolism for DLM, CPM and TPM, respectively.